# Prelinimary Research

### [Company Stock Prices Before and After Public Announcements Related to Oncology Drugs](https://academic.oup.com/jnci/article/103/20/1507/904625#86088399)

Paper from 2011 looks into drugs that were undergoing in phase III trials or for regulatory approval by the US FDA from January 2000 to January 2009. 

" Stock prices of companies that owned such drugs were analyzed for 120 trading days before and after the first public announcement of 1) results of clinical trials with positive and negative outcomes and 2) positive and negative regulatory decisions. All statistical tests were two-sided. "

